Chemours Co (CC) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Chemours Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • Chemours Co Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $52 M, a 64.1% decline year-over-year.
  • Chemours Co Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$330 M, a 167% decline year-over-year.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2023 was -$238 M, a 141% decline from 2022.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2022 was $578 M, a 4.93% decline from 2021.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2021 was $608 M, a 178% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$330 M $52 M -$93 M -64.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$237 M -$18 M +$79 M +81.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$316 M $12 M -$228 M -95% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-27
Q2 2023 -$88 M -$376 M -$577 M -287% Apr 1, 2023 Jun 30, 2023 10-K 2024-03-27
Q1 2023 $489 M $145 M -$89 M -38% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $578 M -$97 M -$329 M -142% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $907 M $240 M +$26 M +12.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-27
Q2 2022 $881 M $201 M +$135 M +205% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-27
Q1 2022 $746 M $234 M +$138 M +144% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-27
Q4 2021 $608 M $232 M +$213 M +1121% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $395 M $214 M +$138 M +182% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $257 M $66 M +$42 M +175% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $215 M $96 M -$4 M -4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $219 M $19 M +$336 M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 -$117 M $76 M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$117 M $24 M -$72 M -75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$45 M $100 M +$6 M +6.38% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$51 M -$317 M -$459 M -323% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-14
Q3 2019 $408 M $76 M -$199 M -72.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $607 M $96 M -$185 M -65.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $792 M $94 M -$203 M -68.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $995 M $142 M -$86 M -37.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $1.08 B $275 M +$68 M +32.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-14
Q2 2018 $1.01 B $281 M +$120 M +74.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-14
Q1 2018 $893 M $297 M +$147 M +98% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-14
Q4 2017 $746 M $228 M +$458 M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-15
Q3 2017 $288 M $207 M +$3 M +1.47% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-15
Q2 2017 $285 M $161 M +$179 M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-15
Q1 2017 $106 M $150 M +$99 M +194% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-15
Q4 2016 $7 M -$230 M -$144 M -167% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $151 M $204 M +$233 M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 -$82 M -$18 M $0 0% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 -$82 M $51 M +$8 M +18.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 -$90 M -$86 M -$165 M -209% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $75 M -$29 M -$136 M -127% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $211 M -$18 M -$134 M -116% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $345 M $43 M -$55 M -56.1% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $400 M $79 M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $107 M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $116 M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $98 M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.